Press Releases April 23, 2026 04:05 PM

SoundThinking Announces First Quarter 2026 Financial Results Date and Conference Call

SoundThinking announces Q1 2026 financial results release date and conference call details

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
SSTI

SoundThinking, Inc., a Nasdaq-listed public safety technology firm, announced it will release its financial results for Q1 2026 after market close on May 14, 2026, followed by a conference call to discuss the results and outlook. The company continues to provide AI-driven public safety solutions to over 300 customers and around 2,100 agencies.

SoundThinking Announces First Quarter 2026 Financial Results Date and Conference Call
SSTI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • SoundThinking operates in public safety technology, offering AI-driven solutions such as acoustic gunshot detection and automated license plate recognition.
  • The company serves a large client base including law enforcement and security professionals, highlighting its market penetration in the public safety sector.
  • The upcoming financial results release and conference call provide investors with updated company performance and future outlook information.

FREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- SoundThinking, Inc. (Nasdaq: SSTI) (“SoundThinking” or the “Company”), a leading public safety technology company, today announced the date for the release of its financial results for the first quarter ended March 31, 2026.

SoundThinking will release its first quarter 2026 financial results after the market closes on Thursday, May 14, 2026. The Company will host a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) on that day to discuss its financial results and outlook.

Those wishing to participate via webcast should access the call through SoundThinking’s Investor Relations website at ir.soundthinking.com. Those wishing to participate via telephone may dial in at 1-877-407-8029 (USA) or 1-201-689-8029 (International). The replay will be available via webcast through SoundThinking’s Investor Relations website.

About SoundThinking
SoundThinking, Inc. (Nasdaq: SSTI) is a leading public safety technology company that delivers AI- and data-driven solutions for law enforcement, civic leadership, and security professionals. SoundThinking is trusted by more than 300 customers and has worked with approximately 2,100 agencies to drive more efficient, effective, and equitable public safety outcomes. The company’s SafetySmart™ platform includes ShotSpotter®, the leading acoustic gunshot detection system; CrimeTracer™, the largest crime data set for investigative lead generation; PlateRanger™ powered by Rekor®, a leading ALPR solution; and SafePointe®, an AI-based weapons detection system. SoundThinking has been designated a Great Place to Work® Company.

Company Contact:
Alan Stewart, CFO
SoundThinking, Inc.
+1 (510) 794-3100
astewart@soundthinking.com

Investor Relations Contact:
Ankit Hira
Solebury Strategic Communications for SoundThinking, Inc.
+1 (203) 546-0444
ahira@soleburystrat.com


Risks

  • Financial results could disappoint relative to market expectations, affecting stock performance.
  • Dependence on public safety budgets and government agencies may expose the company to sector-specific funding risks.
  • General economic or regulatory changes impacting AI and surveillance technologies could create uncertainties for the company.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026